Periodontal bone defects,primarily caused by periodontitis,are highly prevalent in clinical settings and manifest as bone fenestration,dehiscence,or attachment loss,presenting a significant challenge to oral health.In...Periodontal bone defects,primarily caused by periodontitis,are highly prevalent in clinical settings and manifest as bone fenestration,dehiscence,or attachment loss,presenting a significant challenge to oral health.In regenerative medicine,harnessing developmental principles for tissue repair offers promising therapeutic potential.Of particular interest is the condensation of progenitor cells,an essential event in organogenesis that has inspired clinically effective cell aggregation approaches in dental regeneration.However,the precise cellular coordination mechanisms during condensation and regeneration remain elusive.Here,taking the tooth as a model organ,we employed single-cell RNA sequencing to dissect the cellular composition and heterogeneity of human dental follicle and dental papilla,revealing a distinct Platelet-derived growth factor receptor alpha(PDGFRA)mesenchymal stem/stromal cell(MSC)population with remarkable odontogenic potential.Interestingly,a reciprocal paracrine interaction between PDGFRA^(+)dental follicle stem cells(DFSCs)and CD31^(+)Endomucin^(+)endothelial cells(ECs)was mediated by Vascular endothelial growth factor A(VEGFA)and Platelet-derived growth factor subunit BB(PDGFBB).This crosstalk not only maintains the functionality of PDGFRA^(+)DFSCs but also drives specialized angiogenesis.In vivo periodontal bone regeneration experiments further reveal that communication between PDGFRA+DFSC aggregates and recipient ECs is essential for effective angiogenic-osteogenic coupling and rapid tissue repair.Collectively,our results unravel the importance of MSC-EC crosstalk mediated by the VEGFA and PDGFBB-PDGFRA reciprocal signaling in orchestrating angiogenesis and osteogenesis.These findings not only establish a framework for deciphering and promoting periodontal bone regeneration in potential clinical applications but also offer insights for future therapeutic strategies in dental or broader regenerative medicine.展开更多
目的:探讨PDGFR-αASODN对视网膜的毒性作用。方法:选择健康成年有色家兔24只,随机分为4组,每组6只;4组兔子3组右眼玻璃体分别注射0.1 m L不同浓度的PDGFR-αASODN/lipofectamine TM 2000溶液,另外1组注射0.1 m L平衡盐溶液作为对照组;...目的:探讨PDGFR-αASODN对视网膜的毒性作用。方法:选择健康成年有色家兔24只,随机分为4组,每组6只;4组兔子3组右眼玻璃体分别注射0.1 m L不同浓度的PDGFR-αASODN/lipofectamine TM 2000溶液,另外1组注射0.1 m L平衡盐溶液作为对照组;4组兔子的左眼不注药。于注药后第1、7、14及28天,对4组兔子的右眼行裂隙灯、间接检眼镜、视网膜电图(ERG)检查;第28天,取4组兔子的眼球,对视网膜组织进行光镜HE、免疫组化及透射电镜的观察。结果:裂隙灯、间接检眼镜检查,各组在各个检查时间点均未发现异常。ERG b波振幅,实验组与对照组比较差异无显著性。注药后第28天,光镜下HE和免疫组化检查,各组视网膜组织均未发现任何病理变化。注药后第28天电镜检查,D组视网膜感光细胞:部分膜盘间隙扩张,部分膜盘融合,少数细胞核周围间隙略增大,其细胞核形态略不规则。结论:玻璃体内注射0.1 m L PDGFR-αASODN/lip2000时,PDGFR-αASODN的浓度≤1.5μmol/L是较为安全的。展开更多
基金supported by grants from the National Key Research and Development Program of China(2022YFA1104400)the National Natural Science Foundation of China(82170988,82371020,82301028,82401201,82471011)+5 种基金the Young Science and Technology Rising Star Project of Shaanxi Province(2024ZC-KJXX-122)the China Postdoctoral Science Foundation(BX20230485)the Project of State Key Laboratory of Oral&Maxillofacial Reconstruction and Regeneration(2024MS04)the Shaanxi Provincial Health Research and Innovation Platform Construction Plan(2024PT-04)the“Rapid Response”Research projects(2023KXKT017 and 2023KXKT090)the Intramural Research Program project founded by Fourth Military Medical University(2024QMJJ008).
文摘Periodontal bone defects,primarily caused by periodontitis,are highly prevalent in clinical settings and manifest as bone fenestration,dehiscence,or attachment loss,presenting a significant challenge to oral health.In regenerative medicine,harnessing developmental principles for tissue repair offers promising therapeutic potential.Of particular interest is the condensation of progenitor cells,an essential event in organogenesis that has inspired clinically effective cell aggregation approaches in dental regeneration.However,the precise cellular coordination mechanisms during condensation and regeneration remain elusive.Here,taking the tooth as a model organ,we employed single-cell RNA sequencing to dissect the cellular composition and heterogeneity of human dental follicle and dental papilla,revealing a distinct Platelet-derived growth factor receptor alpha(PDGFRA)mesenchymal stem/stromal cell(MSC)population with remarkable odontogenic potential.Interestingly,a reciprocal paracrine interaction between PDGFRA^(+)dental follicle stem cells(DFSCs)and CD31^(+)Endomucin^(+)endothelial cells(ECs)was mediated by Vascular endothelial growth factor A(VEGFA)and Platelet-derived growth factor subunit BB(PDGFBB).This crosstalk not only maintains the functionality of PDGFRA^(+)DFSCs but also drives specialized angiogenesis.In vivo periodontal bone regeneration experiments further reveal that communication between PDGFRA+DFSC aggregates and recipient ECs is essential for effective angiogenic-osteogenic coupling and rapid tissue repair.Collectively,our results unravel the importance of MSC-EC crosstalk mediated by the VEGFA and PDGFBB-PDGFRA reciprocal signaling in orchestrating angiogenesis and osteogenesis.These findings not only establish a framework for deciphering and promoting periodontal bone regeneration in potential clinical applications but also offer insights for future therapeutic strategies in dental or broader regenerative medicine.
文摘目的:探讨PDGFR-αASODN对视网膜的毒性作用。方法:选择健康成年有色家兔24只,随机分为4组,每组6只;4组兔子3组右眼玻璃体分别注射0.1 m L不同浓度的PDGFR-αASODN/lipofectamine TM 2000溶液,另外1组注射0.1 m L平衡盐溶液作为对照组;4组兔子的左眼不注药。于注药后第1、7、14及28天,对4组兔子的右眼行裂隙灯、间接检眼镜、视网膜电图(ERG)检查;第28天,取4组兔子的眼球,对视网膜组织进行光镜HE、免疫组化及透射电镜的观察。结果:裂隙灯、间接检眼镜检查,各组在各个检查时间点均未发现异常。ERG b波振幅,实验组与对照组比较差异无显著性。注药后第28天,光镜下HE和免疫组化检查,各组视网膜组织均未发现任何病理变化。注药后第28天电镜检查,D组视网膜感光细胞:部分膜盘间隙扩张,部分膜盘融合,少数细胞核周围间隙略增大,其细胞核形态略不规则。结论:玻璃体内注射0.1 m L PDGFR-αASODN/lip2000时,PDGFR-αASODN的浓度≤1.5μmol/L是较为安全的。
